Proteoglycans are cell surface and extracellular matrix molecules to which long, unbranched glycosaminoglycan side chains are attached. Heparan sulphate, a type of glycosaminoglycan chain, has been proposed as a co-factor necessary for signalling by a range of growth factors. Here we provide evidence that loss of 2-O-sulphation in heparan sulphate leads to a significant reduction in cell proliferation in the developing cerebral cortex. The gene encoding heparan sulphate 2-sulphotransferase (Hs2st) is expressed in embryonic cortex and histological analysis of mice homozygous for a null mutation in Hs2st indicated a reduction in the thickness of the embryonic cerebral cortex. Using 5 0 -bromodeoxyuridine (BrdU) incorporation assays we found a reduction of approximately 40% in labelling indices of cortical precursor cells at E12. Comparison of the fates of cortical cells born on E13 and E15 in Hs2st 2/2 mutant and wildtype littermate embryos revealed no differences in the pattern of cell migration. Our findings suggest a critical role for 2-O-sulphation of heparan sulphate proteoglycan (HSPG) in regulating cell proliferation during development of the cerebral cortex, perhaps through the modulation of cellular responses to growth factor signalling. q
Introduction
Heparan sulphate proteoglycans (HSPGs) are abundant cell-surface and extracellular matrix molecules expressed by most animal cells. They consist of a core protein covalently linked to glycosaminoglycan polysaccharides and are commonly highly modified. HSPGs can be associated with the cell surface, either as transmembrane proteins such as the syndecans or GPI-linked proteins, such as the glypicans. Other HSPGs, such as perlecan, are secreted and associate with the extracellular matrix. HSPGs can interact with a wide variety of proteins, and have been shown to effect signaling by a variety of growth factors. The biological functions of HSPGs have recently been reviewed by Selleck (2000) and Nakato and Kimata (2002) .
The importance of HSPG molecules in embryonic development has become clear through genetic studies in Drosophila (reviewed by Nybakken and Perrimon, 2002) . Genes affecting HS synthesis in Drosophila include sugarless (sgl), which encodes UDP-D-glucose dehydrogenase and loss of which results in almost complete absence of heparan sulphate and chondroitin sulphate molecules (Toyoda et al., 2000) , and Sulfateless (sfl), which encodes one of the modifying enzymes, N-deacetylase/N-sulphotransferase (NDST) and is essential for the sulphation of HS. In these mutants, both wingless (wg, a Drosophila Wnt protein) and fibroblast growth factor (FGF) signalling pathways are severely impaired . Mutations in the Drosophila glypican gene Dally disrupt wg signaling (Tsuda et al., 1999) and there is evidence that the related Dally-like gene also functions in Wnt signaling (Baeg et al., 2001) . The Drosophila mutation, tout velu (ttv), which disrupts the gene encoding an HS polymerase and results in the absence of HS, appears to compromise the transport of hedgehog (Hh) protein (Bellaiche et al., 1998; . Thus, HS is intimately involved in the modulation of signalling by Wnt, FGF and hedgehog factors. At present, the mechanisms involved in vivo are largely unclear.
HSPGs also have important roles during vertebrate development. In humans, mutations in the homologues of ttv, EXT1 and EXT2, cause multiple exostoses syndrome (Lind et al., 1998) . This dominantly inherited disease is characterised by short stature, unequal limb lengths, bone deformities and the presence of bone growths, called exostoses, at the ends of long bones. A more profound defect is seen in mice harbouring a null mutation in Ext1, which leads to an early gastrulation defect (Lin et al., 2000) . There are four NDST genes in the mouse, NDST1 -4. Mice lacking NDST1are inviable, dying either as embryos or perinatally and exhibiting abnormalities of the lung, skull and eye (Ringvall et al., 2000) . NDST2 knockout mice have a less severe phenotype, resulting in abnormal mast cells (Forsberg et al., 1999; Humphries et al., 1999) .
A role for HSPGs in modulation of Wnt signalling in mammals was identified when mice that overexpress Wnt1 in the mammary gland were crossed to syndecan-1 knockout mice. The Wnt1 expressing animals normally develop mammary tumours at high frequency, but double-mutants were highly resistant to Wnt1-induced tumourigenesis (Alexander et al., 2000) . Further, the recently-described extracellular sulphatase Qsulf1 regulates heparan-dependent Wnt signalling through desulphation of cell surface HSPGs (Dhoot et al., 2001) .
Compelling evidence for tissue-type selectivity of HS function in vertebrate development comes from studies of mouse embryos that are homozygous for a gene-trap mutation in the gene encoding heparan sulphate 2-sulphotransferase (Hs2st) which sulphates heparan sulphate specifically at the 2-O position of hexuronic acid residues (Bullock et al., 1998) . Homozygotes die perinatally, mutant embryos showing absence of kidney induction and defects of the eye and skeleton (Bullock et al., 1998) . These mutant mice have a relatively restricted phenotype, given that the gene is widely expressed from early developmental stages. Embryonic fibroblasts derived from Hs2st 2/2 mice completely lack 2-O-sulphation, demonstrating that the mutation is a true null (Merry et al., 2001) .
Some of the most detailed biochemical studies on the specificity of HS-ligand interactions have used FGFs and FGF receptors (FGFR). Here, optimal FGF2 binding to FGFR1 depends on the presence of 2-O-sulphated HS (Pye et al., 1998) . In agreement with this, the ability of HS from Hs2st 2/2 mouse embryos to bind FGF2 is dramatically impaired (Merry et al., 2001) . Thus, the in vivo consequences of loss of Hs2st function might be expected to include effects upon FGF-dependent processes.
HSPGs have been implicated in the regulation of a number of processes during embryonic development of the central nervous system, including neurogenesis, axonal guidance and synapse development (reviewed by Yamaguchi, 2001 ). As discussed above, there is considerable evidence that HSPG influences signalling by members of the FGF, Wnt and Hedgehog families. Members of each of these families play important roles in the patterning of the mammalian CNS. Therefore it seemed likely that loss of Hs2st activity would have important consequences for CNS development. In this paper, we present evidence of a critical role for HS modification in the development of the mammalian CNS.
Results

Analysis of forebrain development in Hs2st mutant mice
The mutation in Hs2st was generated by gene-trapping, resulting in the incorporation of a lacZ reporter gene into the mutant allele. Expression of the lacZ reporter has been shown to reflect closely expression of the endogenous Hs2st gene, allowing us to deduce the Hs2st expression pattern simply by examining b-galactosidase activity (Bullock et al., 1998) . We found that Hs2st is expressed throughout the telencephalon at E12, at the height of neurogenesis, though expression is not seen in the dorsal thalamus, which subsequently projects to the neocortex (Fig. 1A) . At E14.5, high levels of lacZ expression are seen in the medial wall of the telencephalon, from which the hippocampus, dentate gyrus and choroid plexus will subsequently arise. LacZ activity is seen throughout dorsal cortex, with an apparent gradient decreasing in the dorso-ventral axis (Fig. 1B) . The highest levels of expression are seen in the ventricular zone. LacZ expression is not detected in the body of the thalamus although faint staining is seen in the extreme medial part. Consistent with this expression pattern, we found a considerable reduction in the thickness of the neocortex in mutant embryos (compare Figs. 1C and D) . The average thickness of cortex at rostral, mid and caudal levels, respectively, was 254^16 mm, 222^10 mm and 177^14 mm in mutant embryos compared with 359^28 mm, 322^26 mm and 234^23 mm in equivalent wild type embryos, a reduction of approximately 30%. The hippocampus is also reduced in size in mutant embryos.
HSPGs have been implicated in the regulation of axon guidance (Walz et al., 1997) and in the development of the thalamocortical axon (TCA) tract (Kinnunen et al., 1999) . Further, 2-O-sulphation of HSPGs has profound effects on axon targeting in the developing Xenopus optic pathway (Irie et al., 2002) . We examined Hs2st mutant embryos for evidence of abnormalities of the TCA tract using DiI labelling to reveal the axons. As shown in Fig. 1E and F, TCA projections are present and appear normal in E19 homozygous mutant embryos in that labeling extended completely from the injection site to the upper layers of the cortex and that no divergent fibres were observed. As homozygous mutant animals die perinatally, it is not possible to examine the TCA projections at later stages.
Analysis of cell proliferation in cortex
The reduction in cortical thickness that we observe in Hs2st 2/2 embryos could arise as a consequence of reduced proliferation or migration, or increased cell death. An analysis of the incidence of cells with apoptotic appearance in wild-type and Hs2st 2/2 cortex and hippocampus failed to show any differences (P. Asavaritikrai and D.J.P., unpublished observations) and so we focussed on proliferation and migration. To determine whether alterations in proliferation of neural precursor cells contribute to the reduced size of cortex and hippocampus in Hs2st mutants, we determined the labelling index (LI) in regions of the embryonic cortex and presumptive hippocampus (Fig. 2) . We first examined proliferation in the dorso-medial wall of the telencephalon at E12. This region encompasses epithelium presumptive for the hippocampus medially and the neocortex dorsally. Embryos were labelled with a single 1 h pulse of BrdU and, since it is highly unlikely that any cell would divide twice between the time of injection and sacrifice, cells were classified as BrdU positive or negative with no distinction of the intensity of the label. In order to ensure that any localised alterations in proliferation would be detected, we analysed every tenth section throughout the full antero-posterior extent of the cortex. Camera lucida drawings were made of the dorso-medial wall of each section counted and a reference point was chosen at the junction between the neuroepithelium of the neocortex and choroid plexus or the equivalent position anteriorly or posteriorly (marked '0 mm' in Fig. 2B -E) . From this reference point, to the dorsal-most aspect of the cortex, the epithelium was divided into six or seven 100 mm bins (as shown in Fig. 2B ). BrdU labelled and unlabelled cells were counted in each of these bins and the LI determined. The analysis was carried out on three homozygous mutant and three wild type embryos. Fig. 2F and G shows representative examples of labeling in wild types and mutants. The average LI plotted against position along the medial to dorsal axis is shown in Fig. 3A . Data from all equivalent points in the full range of sections counted from all three animals of each genotype were averaged, effectively collapsing the data in the antero-posterior dimension. Similarly, Fig. 3B shows average LI against position along the antero-posterior axis. Data from all bins in each section were combined and average labeling indices in equivalent sections from all three animals of each genotype were obtained, effectively collapsing the data in the dorso-medial dimension. The LI in Hs2st 2/2 embryos is consistently lower than that in wild type embryos along the full extent of the dorso-medial axis (Fig. 3A) . The LI in both Hs2st 2/2 and wild type embryos increases progressively from medial to dorsal. Along the antero-posterior axis of the medial telencephalic wall, the LI in Hs2st 2/2 mutant embryos is also consistently lower than that in wild types (Fig. 3B) . In contrast to the dorso-medial axis, no obvious trends are seen in LIs along the anteroposterior axis, either in wild type or Hs2st 2/2 embryos. We also measured LI in lateral cortex at E12 in Hs2st 2/2 and wild type embryos. For each animal, three sections from around the midpoint along the anteroposterior axis of the cortex were chosen and the LI determined in a 100 mm-wide bin spanning the full depth of the cortex from the ventricular edge to the pial edge (marked 'l' in Fig. 2B ). The labeling index in the lateral cortex of mutant embryos showed a decrease of a similar magnitude to that observed in the medial telencephalic wall 
(E, F) Sections of forebrain at E19 stained with DiI to reveal the thalamocortical pathway in wild type (E) and Hs2st
2/2 embryos (F). ctx, cortex; hipp, hippocampus; dt, dorsal thalamus; ge, ganglionic eminence; tct, thalamocortical tract. Scale bars, 50 mm. when compared to wild type littermates (Fig. 3C) . No difference in LI was seen in the dorsal thalamus (Fig. 3C ) where no Hs2st expression was seen at E12 (Fig. 1A) .
Radial migration in Hs2st mutant cortex
In order to examine radial migration of cortical precursor cells we employed BrdU birthdating analysis. Embryos were pulse-labelled with BrdU at E13 or E15 then sacrificed at E19 and the positions of BrdU labelled cells determined (Fig. 4) . High power images of parasagittal sections of the neocortex from comparable levels of each animal were captured using a digital camera. The neocortical wall was divided into ten equally spaced 100 mm-wide bins from the ventricular to pial edge, as shown in Fig. 4A . BrdU labelled cells were classified into two groups, heavily labelled cells (more than half the nucleus covered by reaction product) and lightly labelled cells (less than half the nucleus covered by reaction product). Previous work has shown that heavily labelled cells are those born on the day of injection (first generation), whereas the majority of lightly labelled cells are the product of subsequent progenitor cell divisions (second and third generation cells; Gillies and Price, 1993) . Both heavily and lightly labelled cells were counted in each bin and the numbers averaged across mutant and wild type animals in each group ðn ¼ 3Þ: These figures were plotted against cortical depth ( Fig. 4B -E) .
The positions on E19 of cortical cells born on E13 and E15 in wild type and Hs2st 2/2 mutant embryos are shown in Fig. 4 . In both mutants and wild types, most cells born later than E13 (i.e. lightly labeled following an E13 injection) (Fig. 4C ) migrated to more superficial locations than those adopted by E13-born cells (Fig. 4B) . This is in agreement with the fact that the earliest cells that migrate into the cortical plate form the deepest layers and later immigrants form progressively more superficical layers. In both mutants and wild types, many cells born on or after E15 ( Fig. 4D and E ) also migrated out of the ventricular zone; these cells were probably still migrating when the animals were killed on E19. These data indicate that migration of cortical precursor cells is unaffected in Hs2st 2/2 embryos.
Discussion
We have shown that mice lacking Hs2st exhibit a reduction in the size of the cerebral cortex and that this most likely arises as a consequence of significantly reduced rates of proliferation of cortical precursor cells. Although Hs2st is widely expressed in the developing CNS a number of other aspects of CNS development are unaffected in the mutants. For example, TCA tract development and radial migration of cortical precursor cells are apparently normal in Hs2st 2/2 mutant embryos. Additionally, dorso-ventral patterning of the spinal cord appears unaffected (data not shown). As homozygous Hs2st 2/2 mutants die around the time of birth (most likely due to absence of the kidneys) analysis of the CNS at postnatal stages is not possible.
Reduced cell proliferation in cortex of Hs2st
2/2 mutants
We found a large reduction in the proportion of actively proliferating cells in the cortical ventricular zone of the Hs2st 2/2 embryos, consistent with the reduced size of the cortex observed in the E19 mutant embryos. Evidence of reduced proliferation was found both in different areas of the cortex and at different embryonic stages. Within the cortex itself, there was no evidence for regional differences in the effects of the loss of Hs2st-the extent of the reduction in proliferation was consistent along both anteroposterior and dorso-ventral axes. Thus, localised differences in proliferation that underlie the complex morphogenesis of the medial telencephalic wall appear to be independent of Hs2st activity.
One hypothesis to account for the reduced proliferation in the Hs2st 2/2 cortex is that signaling by a growth factor or factors that normally regulate proliferation is altered in some way. As described above, HSPGs are well known to affect signalling by members of the Wnt, FGF and hedgehog families. In Drosophila, perlecan modulates FGF and hedgehog activity, regulating the proliferation of CNS neuroblasts (Voigt et al., 2002; Park et al., 2003) . Wnts are known to act as mitogens in the developing mammalian CNS (Megason and McMahon, 2002 ) and a number of Wnt genes are expressed in dorsal telencephalon, particularly in the medial wall of the telencephalon (Grove et al., 1998) . FGF2 and its cognate receptor, FGFR1, are expressed in the ventricular zone of the rat cortex throughout the period of neurogenesis (Raballo et al., 2000) . Mice deficient in Fgf2 have been described (Zhou et al., 1998; Dono et al., 1998; Ortega et al., 1998) and show decreased cell numbers in the dorsal telencephalon throughout the period of neurogenesis. Large reductions in both the total number of proliferating cells and the growth fraction were found in the dorsal cortical pseudostratified ventricular epithelium (PVE) of Fgf2 2/2 mutants between E10.5 and E15.5 (Vaccarino et al., 1999; Raballo et al., 2000) . HSPGs have been implicated in modulation of the response of neural precursor cells to FGFs (Nurcombe et al., 1993) . Thus, it seems entirely plausible that loss of Hs2st may lead to decreased proliferation of cortical precursor cells through effects on either Wnt or FGF signalling.
HS derived from Hs2st 2/2 mutant embryonic fibroblasts demonstrates much reduced binding to FGF1 and FGF2 (but not hepatocyte growth factor) in a filter binding assay. Despite this, these cells respond normally to FGF2, as determined both by the activation of MAP kinase (Merry et al., 2001 ) and undergoing a mitotic response (C.L. Merry, personal communication) . This suggests that potentiation of FGF 1 and 2 signalling by HS in these cells does not necessarily require high affinity binding, or that binding and/or signalling via FGFR family members other than FGFR1 may depend less critically upon this modification. A full understanding of the complex interplay between the activity of Hs2st, FGFs, Wnts and their cognate receptors in cortical precursor cells will likely require in vitro analysis.
The absence of any obvious effect upon TCA tract formation in the mutants, despite the documented requirement for HSPG in this process (Kinnunen et al., 1999) , suggests the presence of a mechanism able to compensate for improperly modified HSPGs in some developmental processes. This may reflect variation in the requirements of different signalling molecules for specific HSPG modifications. Alternatively, the increased 6-O-sulphation of HSPG observed in Hs2st mutants (Merry et al., 2001 ) may be sufficient to compensate for any effects of loss of 2-Osulphation in some parts of the developing CNS.
In conclusion, although Hs2st is widespread in the developing CNS, we have found a remarkably specific deficit in proliferation of cortical precursor cells in Hs2st 2/2 embryos. The precise identity of the signalling pathway(s) disrupted in these mutants will be addressed in future studies.
Experimental Procedures
Genotyping of Hs2st mutants and lacZ expression pattern analysis
Mice were from isolated laboratory colonies on a mixed C57Bl/6/129Ola background. Embryonic and adult mice were genotyped as described (Bullock et al., 1998 ). To detect lacZ reporter expression, E12 embryos were dissected from the uterus in M2 medium containing 10% foetal bovine serum (Invitrogen, UK) as described (Hogan et al., 1994) and X-gal-stained overnight according to the method of Beddington et al. (1989) . E14.5 embryos were sectioned at 50 mm on a cryostat and sections were X-gal stained as described by Hebert and McConnell (2000) .
Anatomical analysis
Embryos were processed for wax sectioning and counterstained with haematoxylin and eosin using standard techniques. Cortical thickness was measured in three wild type and three homozygous mutant embryos at E17.5. Photomicrographs were taken of comparable sections from each embryo and cortical thickness was measured at equivalent rostral, mid-cortical and caudal levels positions using Image J image analysis software (NIH). To visualise TCAs with dioctadecyl tetramethylindocarbocyanine perchlorate (DiI; Molecular Probes, USA), E19 embryos were fixed with paraformaldehyde (PFA), small crystals of DiI were placed into the ventro-basal nucleus of the thalamus and, after diffusion, coronal sections were cut with a vibratome, wet-mounted in phosphate buffered saline (PBS), and viewed under rhodamine fluorescence optics.
Bromodeoxyuridine (BrdU) labelling
Pregnant dams were given a single injection of BrdU (70 mg/g in sterile saline intraperitoneal (i.p.)) on either E12, E13 or E15. Embryos were removed 1 h later, in the case of E12 injected animals, or at E19 in other cases. Homozygous and wild type littermates were identified as described above. After dissection, the brains were fixed in 4% PFA for 2 h at room temperature, embedded in wax, serially sectioned at 10 mm (coronally for E12, parasagittally for E19), mounted on poly-L-lysine coated slides and reacted immunohistochemically to reveal BrdU labelling using the peroxidase method described previously (Gillies and Price, 1993) . Labelling indices (LI: labelled cells as a proportion of total cells) were determined in three Hs2st 2/2 and three wild type littermates at E12. Means were compared statistically using Student's t-test. In all cases cell counting was performed blind.
